The US Bankruptcy Court gave an order approving the sale of certain assets of Pear Therapeutics, Inc. on May 23, 2023. The debtor has been authorized to sell its certain assets to Nox Health Group, Inc. for a purchase price of $3.90 million in cash plus assumption of the assumed liabilities plus any cure costs. The debtor’s assets include assets related to Somryst.